Literature DB >> 6610425

Systemic lupus erythematosus with paraproteinemia.

L Rubin, M B Urowitz, W Pruzanski.   

Abstract

Nine patients (2.2%) in a group of 415 who were followed in a longitudinal prospective study of systemic lupus erythematosus (SLE) were found to have various monoclonal (M) proteins in their blood (IgG [6 patients], IgA [2 patients], IgM [1 patient]). No other findings compatible with plasmacytic dyscrasia were found. Bence Jones proteinuria was absent. Bone marrow aspirates and skeletal radiographs did not reveal any associated features of malignancy. Four of the 9 patients were under the age of 50. From the point of view of the M components, 3 groups emerged: transient (2 patients), persistently stable (6 patients), and increasing serum concentrations (1 patient). Using current measures of disease status, no correlation was apparent between the presence, type, and concentration of the M protein and the clinical and laboratory variables of lupus activity. Thus, M proteins were found in 2% of our SLE patients, but their relationship to the polyclonal B cell activation seen in this disorder, or perhaps to therapeutic modalities used in its treatment, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6610425     DOI: 10.1002/art.1780270606

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

Review 1.  Rheumatoid arthritis, malignancy, and paraproteins.

Authors:  C Kelly; H Sykes
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

2.  Increased risk of cancer in patients with systemic lupus erythematosus.

Authors:  T Pettersson; E Pukkala; L Teppo; C Friman
Journal:  Ann Rheum Dis       Date:  1992-04       Impact factor: 19.103

3.  Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.

Authors:  Shir Azrielant; Shmuel Tiosano; Abdulla Watad; Naim Mahroum; Aaron Whitby; Doron Comaneshter; Arnon D Cohen; Howard Amital
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

4.  Lupus/Sjögren's autoantibody specificities in sera with paraproteins.

Authors:  A L Sestak; J B Harley; S Yoshida; M Reichlin
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

5.  Lupus anticoagulant associated syndrome in benign and malignant systemic disease--analysis of ten observations.

Authors:  U Dührsen; D Paar; C Kölbel; A Boekstegers; U Metz-Kurschel; R Wagner; W Kirch; P Meusers; E König; G Brittinger
Journal:  Klin Wochenschr       Date:  1987-09-15

6.  Systemic lupus Erythematosus and IgA multiple myeloma: a rare association?

Authors:  J Bila; N Suvajdzic; I Elezovic; M Colovic; D Boskovic
Journal:  Med Oncol       Date:  2007       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.